Trial intelligence / Profile preview

Visudyne PDT Combined with Avastin in Wet AMD

NCT00359164Phase 2Completed

Sponsor
University of British Columbia
Start
Jul 2006
Primary completion
Jun 2008
Modality
Light/Condition-Responsive Prodrugs
Countries
1
01

Overview

A Phase 2 trial of verteporfin in exudative macular degeneration, sponsored by University of British Columbia. Started Jul 2006; status: completed.

02

Drugs

verteporfin
03

Conditions

exudative macular degeneration

Beyond the preview

Go deeper on NCT00359164.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00359164.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call